SGX203
Paper
Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis
Campieri M, Cottone M, Miglio F et al. Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis. Aliment Pharmacol Ther. 1998;12: 361-366.
Paper
Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes
Nichols WG, Corey L, Gooley T at al. Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes. Blood. 2001;97:867-874.
Paper
Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man
Daley-Yates PT, Price AC, Sisson JR et al. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J of Clin Pharmacol. 2001;51:400-409.
Paper
Systemic adverse events of inhaled coriticosteroids
Lipworth BJ. Systemic adverse events of inhaled coriticosteroids. Arch Int Med. 1999;159:941-955.
Paper
The gastrointestinal passage and release of beclomethasone dipropionate from oral delivery systems in ileostomy volunteers
Burggraaf J, van Haarst AD, Fockens P et al. The gastrointestinal passage and release of beclomethasone dipropionate from oral delivery systems in ileostomy volunteers. Br J Clin Pharmacol. 1998;46: 207-214.
Paper
Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial
McDonald GB, Bouvier M, Hockenbery DM et al. Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial. Gastroenterology. 1998;115:28-35.
Paper
Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial
McDonald GB, Bouvier M, Hockenbery DM, et al. Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized controlled trial. Gastroenterology. 1998;115:28-35.
Paper
Immunological studies of eosinophilic gastro-enteritis and treatment with disodium cromoglycate and beclomethasone dipropionate.
Elkon KB, Siier R, Saftel HC. Immunological studies of eosinophilic gastro-interitis and treatment with disodium cromoglycate and beclomethasone dipropionate. S Afr Med J. 1977;52:838-841.
Paper
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn’s disease. A placebo controlled one year study
Lofberg R, Rutgeerts P, Malchow H et al. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut. 1996;39:82-86.
Paper
Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease
Baehr P, Levine D, Bouvier M, Hockenbery D, Gooley T, Stern J, Martin P, and McDonald G. 1995. Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease. Transplantation 60:1231-8.